Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 39Unknown 6Terminated 6Active not recruiting 3Withdrawn 2Recruiting 1

Sponsor Class

NIH 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 2Myeloid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 24Lymphoma 11Lymphoma, Non-Hodgkin 9Prostatic Neoplasms 8Lymphoma, T-Cell, Peripheral 8Lymphoma, Follicular 7Leukemia 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Neoplasms, Plasma Cell 4Lymphoma, Mantle-Cell 4Hodgkin Disease 3Burkitt Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myasthenia Gravis 2Lymphoma, Large-Cell, Immunoblastic 2Immunoblastic Lymphadenopathy 2Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Plasmablastic Lymphoma 1Pituitary Neoplasms 1Neoplasms, Experimental 1Neoplasms 1Neoplasm Metastasis 1Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1Neoadjuvant Therapy 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1

Interventions

Cytarabine 35Cyclophosphamide 26Etoposide 18Radiotherapy 16Daunorubicin 16Busulfan 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Idarubicin 14Mercaptopurine 12Dexamethasone 12Vincristine 11Thioguanine 9Mitoxantrone 9Doxorubicin 8Asparaginase 8Antilymphocyte Serum 8pegaspargase 7fludarabine phosphate 7Prednisolone 7Polymerase Chain Reaction 7Filgrastim 7Cyclosporine 7Prednisone 6Mycophenolic Acid 5Melphalan 5Leucovorin 5Gene Expression Profiling 5Vindesine 4N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Leukemia × Prednisone × Clear all
NCT00550992 2019-07-30

Interfant06

Dutch Childhood Oncology Group

Phase NA Unknown
445 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute

NCT02660762 2017-06-19

Modified MRCUKALLâ…«/ECOGE2993 Regimen for ALL

Sun Yat-sen University

Phase 2 Unknown
100 enrolled
Other hematologic neoplasm

Leukemia

NCT01005758 2014-01-10

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Unknown
180 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002499 2013-09-20

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 2/3 Unknown
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00764907 2009-07-08

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
4,000 enrolled
Other hematologic neoplasm

Leukemia

NCT00466843 2009-06-02

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Office of Rare Diseases (ORD)

Phase 2 Unknown
54 enrolled
MyeloidOther hematologic neoplasm

Autoimmune Diseases, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡